A summary of the results of East African-British Medical Research Council studies of thiacetazone-containing regimens.
D000351:Africa, Eastern; D000995:Antitubercular Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D004357:Drug Synergism; D005252:Fees, Pharmaceutical; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects; D013828:Thioacetazone / Q000008:administration & dosage* / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin